The Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad challenges, opportunities, and trends that are poised to shape its future. Edited by experts, this book delves into transformative technological advancements, including artificial intelligence, machine learning, big data analytics, and blockchain. These technologies are redefining pharmaceutical research, development, and commercialization, making precision medicine and personalized therapies a reality, while integrating genomic medicine into the pharmaceutical value chain.
Additionally, the book addresses educational implications for academic curricula, emphasizing the need for digital transformation in healthcare delivery models. It scrutinizes regulatory trends and compliance, offering insights into navigating complex landscapes to ensure product quality and safety. The book emphasizes the pharmaceutical industry's role in tackling infectious diseases and health disparities, promoting health equity through innovative drug development and access initiatives. Future trends and predictions are speculated upon, considering demographic shifts and evolving healthcare needs, while market dynamics and commercial strategies are analyzed to equip pharmaceutical companies with practical recommendations for navigating competitive landscapes.
1. Chapter 1. Introduction: navigating the complex landscape of pharma in times of artificial intelligence - p. 1 2. Chapter 2. Disrupting technologies for future pharma: from analytics to super intelligence - p. 31 3. Chapter 3. The role of AI-enabled analytics in healthcare - p. 59 4. Chapter 4. Artificial intelligence in the pharmaceutical industry: applications, challenges, and future directions - p. 75 5. Chapter 5. Trends shaping the future of the pharmaceutical industry - p. 103 6. Chapter 6. AI-driven pharma strategy and operating models: from digital adoption to intelligent transformation - p. 127 7. Chapter 7. Generic drugs and biosimilars: opportunities for access and affordability - p. 157 8. Chapter 8. Over-the-counter medications: meeting consumer needs in the digital age - p. 175 9. Chapter 9. Medical devices and diagnostics: enhancing patient care and outcomes - p. 187 10. Chapter 10. Healthcare access in the changing world: Global challenges, inequiities and future directions - p. 225 11. Chapter 11. Precision medicine: personalizing treatments for improved outcomes - p. 241 12. Chapter 12. Future outlook: Anticipating trends and opportunities in the AI-driven pharmaceutical industry - p. 311 13. Chapter 13. The role of artificial intelligence in transforming clinical research and evidence generation - p. 331 14. Chapter 14. Artificial intelligence in clinical trials: a transformative force - p. 355 15. Chapter 15. The role of learning and development in artificial intelligence-transformed pharma industry - p. 375 16. Chapter 16. Pharma Industry 2040: a catalyst for resilient change - p. 415 17. Index - p. 437
The Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad challenges, opportunities, and trends that are poised to shape its future. Edited by experts, this book delves into transformative technological advancements, including artificial intelligence, machine learning, big data analytics, and blockchain. These technologies are redefining pharmaceutical research, development, and commercialization, making precision medicine and personalized therapies a reality, while integrating genomic medicine into the pharmaceutical value chain.
Additionally, the book addresses educational implications for academic curricula, emphasizing the need for digital transformation in healthcare delivery models. It scrutinizes regulatory trends and compliance, offering insights into navigating complex landscapes to ensure product quality and safety. The book emphasizes the pharmaceutical industry's role in tackling infectious diseases and health disparities, promoting health equity through innovative drug development and access initiatives. Future trends and predictions are speculated upon, considering demographic shifts and evolving healthcare needs, while market dynamics and commercial strategies are analyzed to equip pharmaceutical companies with practical recommendations for navigating competitive landscapes.
1. Chapter 1. Introduction: navigating the complex landscape of pharma in times of artificial intelligence - p. 1 2. Chapter 2. Disrupting technologies for future pharma: from analytics to super intelligence - p. 31 3. Chapter 3. The role of AI-enabled analytics in healthcare - p. 59 4. Chapter 4. Artificial intelligence in the pharmaceutical industry: applications, challenges, and future directions - p. 75 5. Chapter 5. Trends shaping the future of the pharmaceutical industry - p. 103 6. Chapter 6. AI-driven pharma strategy and operating models: from digital adoption to intelligent transformation - p. 127 7. Chapter 7. Generic drugs and biosimilars: opportunities for access and affordability - p. 157 8. Chapter 8. Over-the-counter medications: meeting consumer needs in the digital age - p. 175 9. Chapter 9. Medical devices and diagnostics: enhancing patient care and outcomes - p. 187 10. Chapter 10. Healthcare access in the changing world: Global challenges, inequiities and future directions - p. 225 11. Chapter 11. Precision medicine: personalizing treatments for improved outcomes - p. 241 12. Chapter 12. Future outlook: Anticipating trends and opportunities in the AI-driven pharmaceutical industry - p. 311 13. Chapter 13. The role of artificial intelligence in transforming clinical research and evidence generation - p. 331 14. Chapter 14. Artificial intelligence in clinical trials: a transformative force - p. 355 15. Chapter 15. The role of learning and development in artificial intelligence-transformed pharma industry - p. 375 16. Chapter 16. Pharma Industry 2040: a catalyst for resilient change - p. 415 17. Index - p. 437
